Digestive Diseases and Sciences 1993-06-01

Effect of erythromycin derivative EM523L on human interdigestive gastrointestinal tract.

O Kawamura, T Sekiguchi, Z Itoh, S Omura

Index: Dig. Dis. Sci. 38(6) , 1026-31, (1993)

Full Text: HTML

Abstract

We investigated the effect of an erythromycin derivative, EM523L, on interdigestive gastrointestinal motor activity and plasma motilin concentrations in three healthy volunteers using an infused catheter system. We administered doses of 500, 1000, and 2000 micrograms of EM523L to each subject as well as physiological saline. EM523L induced interdigestive migrating contractions (IMCs) that originated in the stomach and migrated to the duodenum. This response was noted in all three subjects after each dose of EM523L, while no IMCs were induced by saline. There were no significant differences in the characteristics of the EM523L-induced IMC and the spontaneous IMC. The initiation time, ie, the interval between the start of EM523L infusion and the onset of the IMC became shorter in a dose-dependent manner. Plasma motilin concentrations increased significantly after EM523L administration, suggesting that motilin is involved in the mechanism of IMC induction by this drug.


Related Compounds

Related Articles:

Sensitive high-performance liquid chromatographic determination of EM523, a new erythromycin derivative, in human plasma and urine with ultraviolet detection using column switching.

[J. Chromatogr. A. 616(1) , 144-50, (1993)]

Comparison of the motor-stimulating action of EM523, an erythromycin derivative, and prostaglandin F2 alpha in conscious dogs.

1993-10-01

[Jpn. J. Pharmacol. 63(2) , 209-17, (1993)]

EM523L, a nonpeptide motilin agonist, stimulates gastric emptying and pancreatic polypeptide secretion.

1996-01-01

[Peptides 17(6) , 895-900, (1996)]

Functional characterization of neural and smooth muscle motilin receptors in the chicken proventriculus and ileum.

1997-08-15

[Regul. Pept. 71(2) , 87-95, (1997)]

In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.

2007-01-01

[Pharmacology 79(3) , 137-48, (2007)]

More Articles...